EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

Circulating microRNAs as Early Biomarkers of Breast Cancer: A Nested Case-Control Study Within a Prospective Cohort in Italy

Lisa Padroni iD, Giorgia Marmiroli, Laura De Marco iD, Valentina Fiano, Saverio Caini iD, Claudia Agnoli, Claudia Vener iD, Vittorio Simeon iD, Salvatore Panico, Luca Manfredi iD, Lorenzo Milani iD, Fulvio Ricceri iD und 1 weitere

International Journal of Molecular Sciences · 16.03.2026 · 27 (6) · 2706

DOI: 10.3390/ijms27062706 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.03.2026. Verfasst von Lisa Padroni und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health (C-BEPH), University of Turin, 10043 Orbass…. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Circulating MicroRNA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating microRNAs (miRNAs) are promising minimally invasive biomarkers for cancer risk assessment, yet prospective evidence for breast cancer (BC) remains limited. We conducted a nested case–control study within a prospective cohort to examine whether pre-diagnostic circulating miRNAs are associated with subsequent BC risk and to explore their potential relevance in prospective population-based settings. Baseline serum from 160 women (80 incident BC cases; 80 matched controls) was analyzed, with a median time to diagnosis of 8.9 years. Eight candidate miRNAs were quantified by droplet digital PCR (ddPCR) and normalized to miR-484. Group differences were evaluated by non-parametric tests, and odds ratios for BC were estimated using logistic regression models adjusted for established risk factors, with Bonferroni correction for multiple testing. Cases and controls were comparable at baseline. Among the candidates, lower circulating miR-181 levels showed a suggestive inverse association with BC risk in fully adjusted models, while lower Let7 levels showed only a non-significant, hypothesis-generating inverse trend that did not survive Bonferroni correction. No other miRNA displayed clear associations with BC risk. These findings, while preliminary, support further large-scale prospective investigations specifically designed to assess predictive performance and external validation. employing standardized pre-analytical and analytical protocols, repeated sampling, and independent replication/external validation to clarify the etiologic relevance and potential risk-prediction value of circulating miRNAs for BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBiomarkers, TumorCirculating MicroRNAHumansFemaleCase-Control StudiesProspective StudiesItalyMiddle AgedAgedMicroRNAsRisk Factors

Stichwörter der Autor:innen

Let7breast cancercirculating microRNAsdroplet digital PCRmiR-181nested case–control

Substanzen

Biomarkers, TumorCirculating MicroRNAMicroRNAs

Autor:innen und Institutionen

  • Department of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health (C-BEPH), University of Turin, 10043 Orbassano, Italy.
  • Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Unit of Cancer Epidemiology, Città Della Salute e Della Scienza University-Hospital and Center for Cancer Prevention (CPO), Via Santena 7, 10126 Turin, Italy.
  • Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.
  • Epidemiology and Prevention Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
  • Medical Statistics Unit, University of Campania "Luigi Vanvitelli", 80138 Napoli, Italy.

ORCID-Profile: Lisa Padroni, Laura De Marco, Saverio Caini, Claudia Vener, Vittorio Simeon, Luca Manfredi, Lorenzo Milani, Fulvio Ricceri, Carlotta Sacerdote

Förderung

  • Ministero della Salute
  • Italian Ministry of Health

Zitieren

APA

Padroni, L., Marmiroli, G., De Marco, L., Fiano, V., Caini, S., Agnoli, C., Vener, C., Simeon, V., Panico, S., Manfredi, L., Milani, L., Ricceri, F., & Sacerdote, C. (2026). Circulating microRNAs as Early Biomarkers of Breast Cancer: A Nested Case-Control Study Within a Prospective Cohort in Italy. International Journal of Molecular Sciences, 27(6), 2706. https://doi.org/10.3390/ijms27062706

Vancouver

Padroni L, Marmiroli G, De Marco L, Fiano V, Caini S, Agnoli C, et al. Circulating microRNAs as Early Biomarkers of Breast Cancer: A Nested Case-Control Study Within a Prospective Cohort in Italy. International Journal of Molecular Sciences. 2026;27(6):2706. doi:10.3390/ijms27062706

BibTeX
@article{Padroni2026,
  author = {Padroni, Lisa and Marmiroli, Giorgia and De Marco, Laura and Fiano, Valentina and Caini, Saverio and Agnoli, Claudia and Vener, Claudia and Simeon, Vittorio and Panico, Salvatore and Manfredi, Luca and Milani, Lorenzo and Ricceri, Fulvio and Sacerdote, Carlotta},
  title = {Circulating microRNAs as Early Biomarkers of Breast Cancer: A Nested Case-Control Study Within a Prospective Cohort in Italy},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2706},
  doi = {10.3390/ijms27062706}
}
Kostenlos starten →